BB BIOTECH overview

EQS-News: BB BIOTECH AG / Key word(s): Annual Report Annual Report 2024: BB Biotech positions for structural sector recovery amid shifting market dynamics 21.02.2025 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. Media release as at February 21, 2025 Annual Report 2024: BB Biotech positions for structural sector recovery amid shifting market dynamics 2024, especially the fourth quarter, signaled the early stage of a structural recovery in biotech, driven...

EQS-Ad-hoc: BB BIOTECH AG / Key word(s): Annual Report/Dividend BB Biotech AG publishes its 2024 annual report 21-Feb-2025 / 07:00 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR February 21, 2025 Annual report of BB Biotech AG as at December 31, 2024 BB Biotech AG publishes its...

EQS-Ad-hoc: BB BIOTECH AG / Key word(s): Annual Results BB Biotech AG closes the 2024 fiscal year with a profit 24-Jan-2025 / 07:00 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR January 24, 2025 BB Biotech AG closes the 2024 fiscal year with a profit In accordance with...

EQS-News: BB BIOTECH AG / Key word(s): Annual Results/Dividend BB Biotech: Preliminary full-year 2024 results and dividend proposal 24.01.2025 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. Media release as of January 24, 2025 BB Biotech: Preliminary full-year 2024 results and dividend proposal BB Biotech AG reports the following preliminary and unaudited figures for 2024: Full-year 2024: BB Biotech shares delivered a total return of -13.5% in CHF and...

Edison Investment Research Limited Edison issues report on BB Biotech (BION) 22-Jan-2025 / 13:31 GMT/BST The issuer is solely responsible for the content of this announcement. London, UK, 22 January 2025 Edison issues report on BB Biotech (BION) Edison issues report on BB Biotech (BION). BB Biotech (BION) is the largest biotech investor among its investment company peers. The company is focused on achieving long-term capital growth by investing in high-quality biotech assets developing and...

BB Biotech is managed by Bellevue Asset Management, a Swiss-based asset manager specialising in healthcare investments....

EQS-Ad-hoc: BB BIOTECH AG / Key word(s): Interim Report BB Biotech AG publishes its interim report 25-Oct-2024 / 07:00 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR October 25, 2024 BB Biotech AG publishes its interim report BB Biotech AG (ISIN CH0038389992) today published...

EQS-News: BB BIOTECH AG / Key word(s): Interim Report BB Biotech: Strategic reallocation of portfolio assets progressing 25.10.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. Media release as at October 25, 2024 Portfolio of BB Biotech AG as at September 30, 2024 BB Biotech: Strategic reallocation of portfolio assets progressing In the third quarter of 2024, stock markets remained volatile. The recent rate cut by the US central bank has improved the...